Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data.

Publication Type:

Journal Article


Lancet, Volume 381, Issue 9880, p.1827-34 (2013)


2013, May 2013, Public Health Sciences Division


Tamoxifen and raloxifene reduce the risk of breast cancer in women at elevated risk of disease, but the duration of the effect is unknown. We assessed the effectiveness of selective oestrogen receptor modulators (SERMs) on breast cancer incidence.